Haemopharm Gold winner at CPhI Pharma Awards 2012 - Best Innovation of the Year
Who we are
“Innofamily since 70’s”
Paolo Gobbi Frattini Company
Paolo Gobbi Frattini S.r.l. Unipersonale was founded in the 1970s based on the family business where Renzo Gobbi Frattini (father), a pioneer in the automated production of flexible bags and infusion sets, was the creator of major technological innovations with important patents for products and production processes that are still very relevant today.
Over the years, Paolo Gobbi Frattini through the company that bears his name, has founded several other companies as sole partner, including Haemopharm, and has continued the tradition of innovation in the biomedical sector. The company has developed proprietary process machines and holds multiple product patents for drug management through biomedical bags and related accessories.
Production
The Paolo Gobbi Frattini Group srl Unipersonale manufactures flexible bags for sterile solutions in both PVC and PVC-FREE materials, as well as drug reconstitution and delivery systems and components for advanced therapeutic applications. Raw materials are carefully selected based on strict criteria of biocompatibility with molecules, along with suitable oxygen and vapor barriers. The company stands out for its level of specialization, a continuous commitment to research and development of innovative solutions, with a focus on designing cutting-edge systems and components for drug reconstitution and delivery, many of which are patented. The Paolo Gobbi Frattini Group srl Unipersonale advanced bag systems and their accessories are developed and produced entirely in-house at the Tovo S. Agata (SO) plant in Lombardy, Italy, in compliance with the strictest and highest quality standards.
Proprietary technology of production lines
A key competitive advantage lies is the exclusive, proprietary technology of its production lines, which has been a hallmark of the company since its inception. Modular business management ensures maximum efficiency through versatile, state-of-the-art processes, delivering high product reliability and consistent performance over time.
Direct involvement of ownership in business operations
Paolo Gobbi Frattini holds 100 % ownership of all group companies and is actively involved as CEO, ensuring a long-term perspective. This hands-on approach is a defining aspect of corporate identity, facilitating communication and accelerating decision-making processes, to better meet the Clients’ needs.
Strategic Guidelines
Our mission & vision
The mission of the Paolo Gobbi Frattini Group srl Unipersonale is to consolidate its leadership in process and product technology, establishing itself as “partner of choice” for large enterprises worldwide. The strategy for international expansion is guided by a vision of sustainable and dynamic growth, supported by a modern and efficient organizational structure. This approach enables the Group to excel in highly specialized market segments, offering superior quality products and services that meet the highest standards of excellence.
For over 40 years, a dynamic entrepreneurial spirit and a relentless pursuit of excellence have defined the history of Paolo Gobbi Frattini Group srl Unipersonale. At the core of the Company’s strategy lie four fundamental strategic pillars that shape its Vision: TOTAL QUALITY, INNOVATION, DIVERSIFICATION and PARTNERSHIP.
A Global Business Network
The ability to maintain a strong presence in the global market is a cornerstone of the company’s policy. Customers increasingly value collaborations with industry leaders who not only deliver products of excellence but also ensure a widespread presence across key regions worldwide through strategic partnerships.
To achieve these objectives, Paolo Gobbi Frattini Group srl Unipersonale has established commercial agreements over the years in Europe, North and South America, Australia, the Middle East, and the Far East. These alliances enable the Group to maintain an active presence in the most strategically significant areas for its business.
The group
Haemopharm is a company that is part of the Paolo Gobbi Frattini Group srl Unipersonale. Its mission is marketing, digital marketing and IP for all activities of the Paolo Gobbi Frattini Group.
Quatalia Science is mainly in charge of the pharmaceutical division of the group including the drug regulatory part.
LUscientific is a business platform that also includes the marketing of pharmaceutical raw materials.
Both Quatalia and LUscientific are based in Belgrade, Serbia, enabling local business consolidation and facilitating penetration into emerging markets.
A network of partnerships and business relationships, on a national and international scale, allows the Paolo Gobbi Frattini Group srl Unipersonale to extend its core business and diversify its offering through collaboration with important players in the sector.
In May 2005, Haemopharm signed a cooperation agreement with SIAD Healthcare (now Medigas Italia) for the development, production and marketing of a new line of stem cell and tissue cryopreservation systems: SAFE2
The agreement with Medigas Italia expands Haemopharm’s presence in a new market segment and allows it to be joined by a trusted Partner to continue the search for increasingly innovative solutions for cell therapies. The goal for both companies is to offer a product line that fully meets the rigorous needs of cryopreservation banks.
The ongoing collaboration with Medigas Italia materialized in 2015 in a contractual joint venture: ADVATIS, “Advanced Therapies Innovative Solutions,” was born, providing innovative solutions in the field of cryopreservation and cell therapies and offering a wide range of products to cover the different stages of stem cell and tissue collection, handling and storage. With a high level of flexibility and with the support of the R&D team, ADVATIS can offer tailor-made solutions to meet any customer need.
St. AGATHA: From industrial research, to therapy
It is a unique medical centre located within the Paolo Gobbi Frattini Srl Unipersonale industry. This clinical division combines the medical-scientific world with the industrial production of advanced therapeutic systems.
Corporate Responsibility
The success of Paolo Gobbi Frattini Group srl Unipersonale is founded on a solid network of core values, upheld daily by the commitment of its team.
Responsibility, work ethics, reliability, respect for individuals, transparency in corporate management, fairness in human resource practices, clarity in contracts, loyalty to commitments, compliance with laws, and respect for institutions in every Country: these are the guiding principles that define the Company’s approach. These values are seamlessly integrated with a Client-centric culture, aimed at building strong and enduring partnerships.
The Group’s sense of responsibility extends to environmental sustainability, pursuing technical solutions that optimize resource utilization and reduce environmental impact. Waste materials are supplied to specialized recycling companies, while most of energy needs is met through the Group’s own photovoltaic plant.